Emerging Therapeutics for APOL1-Mediated Kidney Disease

Emerging Therapeutics for APOL1-Mediated Kidney Disease

APOL1 Mediated Kidney Disease: A Conversation with Dr. Kirk CampbellПодробнее

APOL1 Mediated Kidney Disease: A Conversation with Dr. Kirk Campbell

Webinar | APOL1-mediated kidney disease: Overview and Implications for Care | AKFПодробнее

Webinar | APOL1-mediated kidney disease: Overview and Implications for Care | AKF

Vertex Forward: Exploring APOL1-Mediated Kidney Disease (AMKD) | Vertex PharmaceuticalsПодробнее

Vertex Forward: Exploring APOL1-Mediated Kidney Disease (AMKD) | Vertex Pharmaceuticals

NMQF Webinar: Understanding Genetic Kidney Diseases: Insights into APOL1Подробнее

NMQF Webinar: Understanding Genetic Kidney Diseases: Insights into APOL1

Emerging Therapeutics: APOL1-Mediated Kidney DiseaseПодробнее

Emerging Therapeutics: APOL1-Mediated Kidney Disease

Living with APOL1-mediated kidney disease: Dr. Kendra Richardson’s story | Vertex PharmaceuticalsПодробнее

Living with APOL1-mediated kidney disease: Dr. Kendra Richardson’s story | Vertex Pharmaceuticals

Emerging Research with Global Implications: Identification & Diagnosis of Kidney Diseases - APOL1Подробнее

Emerging Research with Global Implications: Identification & Diagnosis of Kidney Diseases - APOL1

APOL1-mediated kidney disease | Rare Kidney Disease | AKFПодробнее

APOL1-mediated kidney disease | Rare Kidney Disease | AKF

APOL1-mediated kidney disease: A conversation with Alonzo Mourning and Dr. Gerald Appel | NKFПодробнее

APOL1-mediated kidney disease: A conversation with Alonzo Mourning and Dr. Gerald Appel | NKF

Kevin's Journey | Caring for APOL1-Mediated Kidney Disease | AKFПодробнее

Kevin's Journey | Caring for APOL1-Mediated Kidney Disease | AKF

Emani's Journey | Caring for APOL1-Mediated Kidney Disease | AKFПодробнее

Emani's Journey | Caring for APOL1-Mediated Kidney Disease | AKF

Adriana Hung, MD, MPH - APOL1 Mediated Kidney Disease: Toward Precision Medicine ApproachesПодробнее

Adriana Hung, MD, MPH - APOL1 Mediated Kidney Disease: Toward Precision Medicine Approaches

New Kidney Disease Clinical Trial: VX-840 for APOL1-mediated Kidney DiseaseПодробнее

New Kidney Disease Clinical Trial: VX-840 for APOL1-mediated Kidney Disease

APOL1 - A Story from Bench to BedsideПодробнее

APOL1 - A Story from Bench to Bedside

APOL1-Mediated Kidney DiseaseПодробнее

APOL1-Mediated Kidney Disease

APOL1-Mediated Kidney Disease Spotlight | American Kidney FundПодробнее

APOL1-Mediated Kidney Disease Spotlight | American Kidney Fund

APOL1-Associated Nephropathy: Pathology, Mechanisms, and Clinical Utility - Dr. Barry FreedmanПодробнее

APOL1-Associated Nephropathy: Pathology, Mechanisms, and Clinical Utility - Dr. Barry Freedman

Therochelle's Journey | Caring for APOL1-Mediated Kidney Disease | AKFПодробнее

Therochelle's Journey | Caring for APOL1-Mediated Kidney Disease | AKF